Which opioid receptor subtype is primarily responsible for the analgesic and euphoric effects that lead to opioid dependence?

Explanation

## Opioid Receptor Pharmacology **Key Point:** The μ (mu) opioid receptor is the primary target mediating both therapeutic analgesia and the rewarding/euphoric effects that drive addiction in opioid use disorder. ### Receptor Subtypes and Functions | Receptor | Location | Primary Effects | Role in Addiction | |----------|----------|-----------------|-------------------| | **Mu (μ)** | Periaqueductal gray, nucleus accumbens, striatum | Analgesia, euphoria, respiratory depression, physical dependence | **Primary driver of reward and dependence** | | Delta (δ) | Limbic system, spinal cord | Analgesia, mood modulation | Modulates μ-mediated effects | | Kappa (κ) | Hypothalamus, brainstem | Dysphoria, analgesia, sedation | Opposes μ-mediated reward | | Nociceptin (ORL-1) | Spinal cord, brain | Antinociception, anxiolysis | Minimal role in addiction | **High-Yield:** The μ receptor's presence in the ventral tegmental area (VTA) and nucleus accumbens makes it the critical node in the mesolimbic dopamine reward pathway. Activation here triggers dopamine release, reinforcing drug-seeking behavior and establishing psychological dependence. **Clinical Pearl:** All clinically used opioids (morphine, heroin, methadone, buprenorphine) exert their primary effects through μ receptor agonism. Buprenorphine's partial μ agonist activity is why it has lower abuse potential and is preferred in maintenance therapy. **Mnemonic:** **MUD** = **M**u receptor drives **U**phoria and **D**ependence [cite:Rang & Dale Ch 41] ## Why Mu Dominates 1. **Analgesic threshold**: μ receptors in dorsal horn and brainstem mediate pain relief at lower doses 2. **Reward threshold**: μ receptors in VTA/nucleus accumbens mediate euphoria at similar or slightly higher doses 3. **Physical dependence**: μ receptor desensitization and downregulation cause tolerance and withdrawal 4. **Behavioral reinforcement**: μ-mediated dopamine release in mesolimbic circuit drives compulsive use